MedPath

GLYBURIDE

Glyburide Tablets, USP1.25, 2.5, and 5 mg

Approved
Approval ID

9cdd30e7-512a-4f00-a4de-0a154d143ce9

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 30, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

GLYBURIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71335-0069
Application NumberANDA090937
Product Classification
M
Marketing Category
C73584
G
Generic Name
GLYBURIDE
Product Specifications
Route of AdministrationORAL
Effective DateApril 2, 2021
FDA Product Classification

INGREDIENTS (5)

FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
GLYBURIDEActive
Quantity: 2.5 mg in 1 1
Code: SX6K58TVWC
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GLYBURIDE - FDA Drug Approval Details